SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

GRDN

Guardian Pharmacy Services Inc.
NYSEHealth Care

Latest close: 39.47 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record20321 flagged findings
Reported transactions (Form 4)80since May 28, 2025 · and 27 other holdings
Corporate events (8-K)12since Sep 30, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗
    “…the preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 203)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 10 Form 4 filingsshow all 10hide
  • Sep 28, 26SCHEDULE 13D/A ↗Stake with intent to influence · Thomas J. Salentine, Jr. · 26.4% · event on Sep 27, 26 · amendment
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Sep 10, 268-K ↗Current report · Other events
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results
  • Jun 22, 268-K ↗Current report · A senior executive left or was appointed
  • May 28, 268-K ↗Current report · Entered a material agreement
  • Insider transaction · 3 Form 4 filingsshow all 3hide

203 filings on record, the oldest from Mar 11, 20.

Listing the 25 most recent filings of the 203 on record.

8-Ks, explained

Structure8Governance4
  • Jun 22, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure3 material agreements entered2025 – 2026show all 3hide
    • May 28, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 23, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • May 20, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Mar 28, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 11, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 20, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 30, 24StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Thomas J. Salentine, Jr.26.4%Sep 27, 26SCHEDULE 13D/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • FMR LLC6.5%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • BROWN ADVISORY INC4.5%Dec 31, 25SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
  • Franklin Resources, Inc.4.3%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • The Vanguard Group4.3%Jun 30, 25SCHEDULE 13G/A ↗
  • BlackRock, Inc.4.2%Dec 31, 25SCHEDULE 13G/A ↗2 earlier filings
show 6 more holdershide
  • Wellington Management Group LLP3.1%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • J. Goldman & Co LP2.9%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • TIAA-CREF Investment Management, LLC2.1%May 30, 25SCHEDULE 13G/A ↗
  • Clearbridge Investments, LLC2.0%Jun 30, 25SCHEDULE 13G/A ↗
  • Nuveen Asset Management, LLC0.3%May 30, 25SCHEDULE 13G/A ↗
  • Teachers Advisors, LLC0.1%May 30, 25SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Mar 20, 26Sell$8.2MCardinal Equity Fund, L.P.↗
  • Mar 20, 26Sell$106.0MWILLIAM E BINDLEY↗
  • Mar 20, 26Sell$24.6MJohn Ackerman↗
  • Mar 20, 26Sell$10.3MKendall ForbesSee Remarks↗
  • Mar 20, 26Sell$19.9MFred BurkeSee Remarks↗
  • Mar 20, 26Sell$5.6MDavid K MorrisSee Remarks↗
  • Dec 3, 25Buy$100KSTEVEN D COSLER↗
  • May 28, 25Sell$3.0MJohn Ackerman↗
  • May 28, 25Sell$1.0MCardinal Equity Fund, L.P.↗
Stock compensation, tax and giftsshow the 31 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 27, 26Compensationamount n/aJohn Ackerman↗
  • Sep 27, 26Compensationamount n/aCardinal Equity Fund, L.P.↗
  • Sep 27, 26Compensationamount n/aWILLIAM E BINDLEY↗
  • Sep 27, 26Compensationamount n/aDouglas TownsSee Remarks↗
  • Sep 27, 26Compensationamount n/aRichard EakinsSenior Vice President, Sales↗
  • Sep 27, 26Compensationamount n/aChris CrisafulliSee Remarks↗
  • Sep 27, 26Compensationamount n/aDavid K MorrisSee Remarks↗
  • Sep 27, 26Compensationamount n/aKendall Forbes↗
  • Sep 27, 26Compensationamount n/aJeffrey TuchSee Remarks↗
  • Sep 27, 26Compensationamount n/aFred BurkeSee Remarks↗
  • Sep 27, 26Compensationamount n/aDavid Norman MartinSee Remarks↗
  • Sep 27, 26Compensationamount n/aRobert WeirSee Remarks↗
  • Sep 27, 26Compensationamount n/aWilliam Franklin MuddSee Remarks↗
  • May 5, 26Compensationamount n/aRANDALL J LEWIS↗
  • May 5, 26Compensationamount n/aSTEVEN D COSLER↗
  • Mar 28, 26Compensationamount n/aJohn Ackerman↗
  • Mar 28, 26Compensationamount n/aCardinal Equity Fund, L.P.↗
  • Mar 28, 26Compensationamount n/aWILLIAM E BINDLEY↗
  • Mar 28, 26Compensationamount n/aFred BurkeSee Remarks↗
  • Mar 28, 26Compensationamount n/aDavid K MorrisSee Remarks↗
  • Mar 28, 26Compensationamount n/aKendall ForbesSee Remarks↗
  • Mar 1, 26Compensationamount n/aKendall ForbesSee Remarks↗
  • Mar 1, 26Compensationamount n/aDavid K MorrisSee Remarks↗
  • Dec 4, 25Giftamount n/aKendall ForbesSee Remarks↗
  • Dec 4, 25Giftamount n/aFred BurkeSee Remarks↗
  • Sep 27, 25Compensationamount n/aJohn Ackerman↗
  • Sep 27, 25Compensationamount n/aCardinal Equity Fund, L.P.↗
  • Sep 27, 25Compensationamount n/aWILLIAM E BINDLEY↗
  • Sep 27, 25Compensationamount n/aFred BurkeSee Remarks↗
  • Sep 27, 25Compensationamount n/aDavid K MorrisSee Remarks↗
  • Sep 27, 25Compensationamount n/aKendall ForbesSee Remarks↗

The full record holds 66 transactions and goes back to Sep 27, 24.

Its sector and its market

Guardian Pharmacy Services Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Guardian Pharmacy Services Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Guardian Pharmacy Services Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
203 documents on file, from Mar 11, 2020 to Sep 28, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Guardian Pharmacy Services Inc. (GRDN): stock price history, insider trades and SEC filings — HornScout